Latest On Coherus BioSciences, Inc (CHRS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-31 18:21 EST | News | Coherus BioSciences falls after regulatory update on cancer drug | N/A |  |
| 2023-05-16 11:48 EST | News | Coherus BioSciences down 11%, prices $50M offering | N/A | |
| 2023-05-15 22:12 EST | News | Coherus BioSciences plans for $50M stock offering, shares fall | N/A | |
| 2023-05-10 01:15 EST | News | Coherus: Biosimilar And Immuno-Oncology Pipeline Setup Could Pay Off | N/A | |
| 2023-05-08 22:15 EST | News | Coherus BioSciences Non-GAAP EPS of -$0.75 misses by $0.28, revenue of $32.44M misses by $13.85M | N/A | |
| 2023-05-08 22:14 EST | News | Coherus BioSciences, Inc. (CHRS) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-07 20:25 EST | News | Coherus BioSciences Q1 2023 Earnings Preview | N/A | |
| 2023-05-01 20:30 EST | News | Coherus spikes as Truist starts at Buy on biosimilar business | N/A | |
| 2023-04-28 18:02 EST | News | Coherus Still Looks Good, Multiple Catalysts This Year (Rating Downgrade) | N/A | |
| 2023-03-09 14:38 EST | News | Coherus BioSciences laying off 20% of employees | N/A | |
| 2023-03-07 02:43 EST | News | Coherus BioSciences Non-GAAP EPS of -$0.60 beats by $0.09, revenue of $45.4M misses by $2.57M | N/A | |
| 2023-03-07 02:43 EST | News | Coherus BioSciences, Inc. (CHRS) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-05 21:16 EST | News | Coherus BioSciences Q4 2022 Earnings Preview | N/A | |
| 2023-02-15 22:50 EST | News | Coherus touts late-stage toripalimab overall survival data in nasopharyngeal carcinoma | N/A | |
| 2023-01-31 13:52 EST | News | Coherus BioSciences: Biosimilar Specialist With Approval Shot For Chinese Cancer Drug Looks Like A Buy | N/A | |
| 2023-01-18 05:59 EST | News | Junshi's toripalimab meets main goal of late-stage study in lung cancer subtype | N/A | |
| 2023-01-09 14:36 EST | News | Coherus: Launch Of Humira Biosimilar May Boost Stock | N/A | |
| 2023-01-09 14:35 EST | News | Coherus stock dips amid deal to acquire US rights to Eylea biosimilar FYB203 | N/A | |
| 2022-12-27 20:07 EST | News | Coherus down 10% on BLA action date delay for toripalimab | N/A | |
| 2022-12-23 22:23 EST | News | Coherus sheds 13% on FDA action date for cancer drug | N/A | |
| 2022-12-17 12:34 EST | News | Stocks To Watch: Earnings For Micron, Nike And FedEx + Disney Looks For Avatar Blowout | N/A | |
| 2022-11-09 03:52 EST | News | Coherus BioSciences Non-GAAP EPS of -$0.96 misses by $0.32, revenue of $45.42M misses by $10.94M | N/A | |
| 2022-11-09 03:51 EST | News | Coherus BioSciences, Inc. (CHRS) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-08 09:56 EST | News | Coherus BioSciences Q3 2022 Earnings Preview | N/A | |
| 2022-09-19 20:43 EST | News | Coherus to launch its biosimilar to Roche's eye disorder drug Lucentis in U.S. on Oct. 3 | N/A | |
| 2022-08-24 18:35 EST | News | Coherus: 2022 Is In Many Ways A Make Or Break Year | N/A | |
| 2022-08-07 21:42 EST | News | Coherus BioSciences, Inc.'s (CHRS) CEO Denny Lanfear on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-05 00:52 EST | News | Coherus BioSciences GAAP EPS of -$0.65 beats by $0.21, revenue of $60.2M misses by $1.24M | N/A | |
| 2022-08-03 18:46 EST | News | Coherus stock soars 14% on FDA nod for Roche Lucentis' interchangeable biosimilar Cimerli | N/A | |
| 2022-08-03 18:45 EST | News | Coherus BioSciences Q2 2022 Earnings Preview | N/A | |
| 2022-07-21 09:36 EST | News | Coherus/Junshi's toripalimab gets orphan drug tag in EU for head/neck cancer subtype | N/A | |
| 2022-07-06 20:18 EST | News | Coherus, Shanghai Junshi refiling for toripalimab gets FDA review in rare head/neck cancer | N/A | |
| 2022-05-27 18:07 EST | News | Coherus: Will Its Chinese Gambit Fail? | N/A | |
| 2022-05-06 00:48 EST | News | Coherus BioSciences Non-GAAP EPS of -$1.00 misses by $0.35, revenue of $60.12M misses by $10.42M | N/A | |
| 2022-05-06 00:47 EST | News | Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q1 2022 Earnings Call Transcript | N/A | |
| 2022-05-05 01:14 EST | News | Coherus BioSciences Q1 consensus EPS, revenue estimates down | N/A | |
| 2022-05-02 17:59 EST | News | Coherus, Junshi hit by FDA rejection of cancer therapy | N/A | |
| 2022-04-14 20:48 EST | News | Coherus BioSciences SCLC candidate toripalimab granted Orphan Drug status | N/A | |
| 2022-03-29 23:30 EST | News | Coherus gains after issuing long-term guidance | N/A | |
| 2022-03-17 04:49 EST | News | Coherus Biosciences (CHRS) Investor Presentation - slideshow | N/A | |
| 2022-03-15 19:36 EST | News | Coherus NSCLC treatment toripalimab meets primary endpoint in late-stage trial | N/A | |
| 2022-03-15 19:36 EST | News | Coherus Biosciences appoints chief medical officer | N/A | |
| 2022-03-07 17:34 EST | News | JP Morgan downgrades Coherus BioSciences to neutral on toripalimab uncertainty | N/A | |
| 2022-03-04 20:34 EST | News | Coherus esophageal cancer candidate toripalimab succeeds in late-stage trial | N/A | |
| 2022-02-18 11:03 EST | News | Coherus BioSciences Non-GAAP EPS of -$0.46 beats by $0.08, revenue of $73.37M misses by $9.24M | N/A | |
| 2022-02-18 11:03 EST | News | Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-17 13:50 EST | News | Coherus BioSciences Q4 2021 Earnings Preview | N/A | |
| 2022-02-09 09:17 EST | News | Eli Lilly, Innovent draw negative FDA comments for cancer drug ahead of AdCom meeting | N/A | |
| 2022-02-07 19:37 EST | News | Coherus slips after JPMorgan cut price target on experimental cancer therapy | N/A | |
| 2022-01-12 20:14 EST | News | Coherus BioScience (CHRS) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
About Coherus BioSciences, Inc (CHRS):
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline includes biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar; and CHS-131, a once-daily oral drug candidate for non-alcoholic steatohepatitis and other metabolic conditions. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
General
- Name Coherus BioSciences, Inc
- Symbol CHRS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 317
- Fiscal Year EndDecember
- IPO Date2014-11-06
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.coherus.com
View More
Valuation
- Trailing PE 9.32
- Forward PE 36.76
- Price/Sales (Trailing 12 Mt.) 2.81
- Price/Book (Most Recent Quarter) 4.14
- Enterprise Value Revenue 2.18
- Enterprise Value EBITDA 6.49
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.53
- Next Year EPS Estimate $0.83
- Next Quarter EPS Estimate $0.25
- Profit Margin 28%
- Operating Margin 33%
- Return on Assets 16%
- Return on Equity 68%
- Revenue 475.82 million
- Earnings Per Share $1.62
- Revenue Per Share $6.66
- Gross Profit 295.4 million
- Quarterly Earnings Growth -10.8%
View More
Highlights
- Market Capitalization 1.1 billion
- EBITDA 159.21 million
- PE Ratio -5.46
- Analyst Target Price $27.63
- Book Value Per Share $3.88
View More
Share Statistics
- Shares Outstanding 72.79 million
- Shares Float 59.94 million
- % Held by Insiders 162%
- % Held by Institutions 125.64%
- Shares Short 13.42 million
- Shares Short Prior Month 13.08 million
- Short Ratio 8.33
- Short % of Float 23%
- Short % of Shares Outstanding 18%
View More
Technicals
- Beta 1.34
- 52 Week High $22.22
- 52 Week Low $13.66
- 50 Day Moving Average 17.12
- 200 Day Moving Average 17.79
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Coherus BioSciences, Inc (CHRS) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Coherus BioSciences, Inc (CHRS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $N/A | $0.12 | $0.27 | -54.97% |
| 2020-09-30 | 2020-11-05 | $N/A | $0.33 | $0.34 | -2.68% |
| 2020-06-30 | 2020-08-06 | $N/A | $0.70 | $0.29 | 141.13% |
| 2020-03-31 | 2020-05-07 | $116.18 million | $0.48 | $0.48 | 1.05% |
| 2019-12-31 | 2020-02-27 | $123.86 million | $0.53 | $0.70 | -24.18% |
| 2019-09-30 | 2019-11-06 | $111.68 million | $0.63 | $0.42 | 49.43% |
| 2019-06-30 | 2019-08-01 | $83.43 million | $0.32 | -$0.04 | 878.59% |
| 2019-03-31 | 2019-05-09 | $37.1 million | -$0.29 | -$0.46 | 37.2% |
| 2018-12-31 | 2019-02-28 | $N/A | -$0.92 | -$0.84 | -9.26% |
| 2018-09-30 | 2018-11-08 | $N/A | -$0.87 | -$0.79 | -10.49% |
| 2018-06-30 | 2018-08-08 | $N/A | -$0.68 | -$0.65 | -5.17% |
| 2018-03-31 | 2018-05-10 | $N/A | -$0.74 | -$0.70 | -5.79% |
| 2017-12-31 | 2018-03-08 | $1.56 million | -$0.84 | -$0.80 | -4.84% |
| 2017-09-30 | 2017-11-06 | $-1395000 | -$1.09 | -$0.85 | -27.63% |
| 2017-06-30 | 2017-08-07 | $1.4 million | -$1.08 | -$1.39 | 22.22% |
| 2017-03-31 | 2017-05-08 | $161000 | -$1.54 | -$1.43 | -8.07% |
| 2016-12-31 | 2017-03-13 | $844000 | -$1.71 | -$1.34 | -27.25% |
| 2016-09-30 | 2016-11-09 | $162.84 million | $1.67 | -$1.57 | 206.16% |
| 2016-06-30 | 2016-08-09 | $14.07 million | -$1.72 | -$1.31 | -30.85% |
| 2016-03-31 | 2016-05-09 | $12.36 million | -$1.67 | -$1.42 | -17.61% |
| 2015-12-31 | 2016-02-29 | $10.2 million | -$1.35 | -$1.47 | 8.16% |
| 2015-09-30 | 2015-11-09 | $7.17 million | -$1.86 | ||
| 2015-06-30 | 2015-08-10 | $6.87 million | -$1.56 | ||
| 2015-03-31 | 2015-05-11 | $5.81 million | -$1.22 | ||
| 2014-12-31 | 2015-03-23 | $6.49 million | -$1.47 | -$0.64 | -129.69% |
| 2014-09-30 | 2014-12-15 | $16.05 million | -$1.79 | -$0.86 | -108.14% |
Coherus BioSciences, Inc (CHRS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Coherus BioSciences, Inc (CHRS) Chart:
Coherus BioSciences, Inc (CHRS) News:
Below you will find a list of latest news for Coherus BioSciences, Inc (CHRS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Coherus BioSciences, Inc (CHRS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 | 0.5 | 0.44 | CALL | 0 | 290 | 1246.45 | TRUE | 0 | 0 |
| 2025-05-16 | 1 | 0.1 | CALL | 110 | 1546 | 176.24 | FALSE | 0 | 0 |
| 2025-05-16 | 1.5 | 0.05 | CALL | 0 | 1702 | 236.97 | FALSE | 0 | 0 |
| 2025-05-16 | 2 | 0.04 | CALL | 0 | 530 | 336.85 | FALSE | 0 | 0 |
| 2025-05-16 | 3 | 0.05 | CALL | 0 | 2140 | 460.89 | FALSE | 0 | 0 |
| 2025-05-16 | 4 | 0.08 | CALL | 0 | 17 | 541.21 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 0.5 | 0.05 | PUT | 0 | 1 | 401.45 | FALSE | 0 | 0 |
| 2025-05-16 | 1 | 0.05 | PUT | 0 | 352 | 164.55 | TRUE | 0 | 0 |
| 2025-05-16 | 1.5 | 0.5 | PUT | 0 | 3 | 336.92 | TRUE | 0 | 0 |
| 2025-05-16 | 2 | 0 | PUT | 0 | 0 | 450.82 | TRUE | 0 | 0 |
| 2025-05-16 | 3 | 2.25 | PUT | 0 | 16 | 524.84 | TRUE | 0 | 0 |
| 2025-05-16 | 4 | 0 | PUT | 0 | 0 | 680.64 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 3.29 | PUT | 0 | 15 | 911.92 | TRUE | 0 | 0 |
| 2025-06-20 | 0.5 | 1.1 | CALL | 0 | 9 | 495.09 | TRUE | 0 | 0 |
| 2025-06-20 | 1 | 0.15 | CALL | 0 | 222 | 93.21 | FALSE | 0 | 0 |
| 2025-06-20 | 1.5 | 0.1 | CALL | 0 | 99 | 190.24 | FALSE | 0 | 0 |
| 2025-06-20 | 2 | 0 | CALL | 0 | 0 | 299.92 | FALSE | 0 | 0 |
| 2025-06-20 | 3 | 0 | CALL | 0 | 0 | 232.76 | FALSE | 0 | 0 |
| 2025-06-20 | 4 | 0 | CALL | 0 | 0 | 633.46 | FALSE | 0 | 0 |
| 2025-06-20 | 0.5 | 0 | PUT | 0 | 0 | 486.45 | FALSE | 0 | 0 |
| 2025-06-20 | 1 | 0.2 | PUT | 0 | 25 | 91.01 | TRUE | 0 | 0 |
| 2025-06-20 | 1.5 | 0 | PUT | 0 | 0 | 126.15 | TRUE | 0 | 0 |
| 2025-06-20 | 2 | 0 | PUT | 0 | 0 | 262.28 | TRUE | 0 | 0 |
| 2025-06-20 | 3 | 0 | PUT | 0 | 0 | 308.27 | TRUE | 0 | 0 |
| 2025-06-20 | 4 | 0 | PUT | 0 | 0 | 328.49 | TRUE | 0 | 0 |
| 2025-08-15 | 0.5 | 0.51 | CALL | 0 | 284 | 248.9 | TRUE | 0 | 0 |
| 2025-08-15 | 1 | 0.26 | CALL | 14 | 981 | 127.72 | FALSE | 0.06 | 0.3 |
| 2025-08-15 | 1.5 | 0.1 | CALL | 20 | 143 | 111.65 | FALSE | 0.1 | 0 |
| 2025-08-15 | 2 | 0.1 | CALL | 0 | 62 | 114.65 | FALSE | 0 | 0 |
| 2025-08-15 | 3 | 0.35 | CALL | 0 | 5 | 227.3 | FALSE | 0 | 0 |
| 2025-08-15 | 4 | 0.16 | CALL | 0 | 2 | 353.05 | FALSE | 0 | 0 |
| 2025-08-15 | 5 | 0.05 | CALL | 0 | 1 | 373.07 | FALSE | 0 | 0 |
| 2025-08-15 | 0.5 | 0 | PUT | 0 | 0 | 246.69 | FALSE | 0 | 0 |
| 2025-08-15 | 1 | 0.3 | PUT | 0 | 30 | 163.11 | TRUE | 0 | 0 |
| 2025-08-15 | 1.5 | 0.85 | PUT | 0 | 0 | 86.66 | TRUE | 0 | 0 |
| 2025-08-15 | 2 | 0.59 | PUT | 0 | 3 | 100.1 | TRUE | 0 | 0 |
| 2025-08-15 | 3 | 0 | PUT | 0 | 0 | 162.53 | TRUE | 0 | 0 |
| 2025-08-15 | 4 | 0 | PUT | 0 | 0 | 209.08 | TRUE | 0 | 0 |
| 2025-08-15 | 5 | 0 | PUT | 0 | 0 | 247.12 | TRUE | 0 | 0 |
| 2025-11-21 | 0.5 | 0 | CALL | 0 | 0 | 174.67 | TRUE | 0 | 0 |
| 2025-11-21 | 1 | 0.68 | CALL | 0 | 225 | 103.78 | FALSE | 0 | 0 |
| 2025-11-21 | 1.5 | 0 | CALL | 0 | 0 | 165.68 | FALSE | 0 | 0 |
| 2025-11-21 | 2 | 0.12 | CALL | 0 | 34 | 91.91 | FALSE | 0 | 0 |
| 2025-11-21 | 3 | 0.19 | CALL | 0 | 5 | 131.33 | FALSE | 0 | 0 |
| 2025-11-21 | 4 | 0 | CALL | 0 | 0 | 125.03 | FALSE | 0 | 0 |
| 2025-11-21 | 0.5 | 0 | PUT | 0 | 0 | 212.32 | FALSE | 0 | 0 |
| 2025-11-21 | 1 | 0 | PUT | 0 | 0 | 80.92 | TRUE | 0 | 0 |
| 2025-11-21 | 1.5 | 0 | PUT | 0 | 0 | 75.4 | TRUE | 0 | 0 |
| 2025-11-21 | 2 | 0 | PUT | 0 | 0 | 101.42 | TRUE | 0 | 0 |
| 2025-11-21 | 3 | 0 | PUT | 0 | 0 | 145.28 | TRUE | 0 | 0 |
| 2025-11-21 | 4 | 0 | PUT | 0 | 0 | 241.04 | TRUE | 0 | 0 |
| 2026-01-16 | 0.5 | 0.54 | CALL | 0 | 969 | 168.87 | TRUE | 0 | 0 |
| 2026-01-16 | 1 | 0.35 | CALL | 115 | 1894 | 107.53 | FALSE | 0 | 0 |
| 2026-01-16 | 1.5 | 0.21 | CALL | 0 | 79 | 84.25 | FALSE | 0 | 0 |
| 2026-01-16 | 2 | 0.2 | CALL | 2 | 979 | 121.89 | FALSE | 0.05 | 0.33 |
| 2026-01-16 | 3 | 0.1 | CALL | 0 | 1483 | 115.5 | FALSE | 0 | 0 |
| 2026-01-16 | 4 | 0.1 | CALL | 0 | 39 | 121.72 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0.09 | CALL | 0 | 391 | 121.23 | FALSE | 0 | 0 |
| 2026-01-16 | 7 | 0.05 | CALL | 0 | 22 | 137.25 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 0.2 | CALL | 0 | 42 | 177.55 | FALSE | 0 | 0 |
| 2026-01-16 | 0.5 | 0.12 | PUT | 0 | 5 | 93.14 | FALSE | 0 | 0 |
| 2026-01-16 | 1 | 0.35 | PUT | 0 | 128 | 64.42 | TRUE | 0 | 0 |
| 2026-01-16 | 1.5 | 0.69 | PUT | 0 | 282 | 138.5 | TRUE | 0 | 0 |
| 2026-01-16 | 2 | 1.05 | PUT | 0 | 61 | 116.97 | TRUE | 0 | 0 |
| 2026-01-16 | 3 | 1.92 | PUT | 0 | 4 | 111.65 | TRUE | 0 | 0 |
| 2026-01-16 | 4 | 0 | PUT | 0 | 0 | 185.74 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 4.22 | PUT | 0 | 2 | 168.21 | TRUE | 0 | 0 |
| 2026-01-16 | 7 | 3.3 | PUT | 0 | 0 | 171.34 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 8.92 | PUT | 0 | 0 | 218.64 | TRUE | 0 | 0 |
Latest CHRS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 90 | $6.2 |
| Jun 13, 2022 7:59 PM EST | 79 | $6.195 |
| Jun 13, 2022 7:59 PM EST | 100 | $6.2 |
| Jun 13, 2022 7:59 PM EST | 80 | $6.2 |
| Jun 13, 2022 7:59 PM EST | 20 | $6.195 |
Coherus BioSciences, Inc (CHRS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm |
| 2019-10-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1512762/000000000019014253/0000000000-19-014253-index.htm |
| 2019-10-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1512762/000000000019014825/0000000000-19-014825-index.htm |
| 2019-11-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1512762/000000000019015589/0000000000-19-015589-index.htm |
| 2020-01-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000001961720000014/0000019617-20-000014-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000021545719003360/0000215457-19-003360-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000031506619000925/0000315066-19-000925-index.htm |
| 2020-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000031506620000020/0000315066-20-000020-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000083423720004607/0000834237-20-004607-index.htm |
| 2020-06-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000083423720009554/0000834237-20-009554-index.htm |
| 2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm |
| 2018-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924318020572/0000899243-18-020572-index.htm |
| 2018-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924318022461/0000899243-18-022461-index.htm |
| 2018-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924318024270/0000899243-18-024270-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924318025185/0000899243-18-025185-index.htm |
| 2018-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924318029451/0000899243-18-029451-index.htm |
| 2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924318029452/0000899243-18-029452-index.htm |
| 2019-01-14 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001120/0000899243-19-001120-index.htm |
| 2019-01-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001121/0000899243-19-001121-index.htm |
| 2019-01-15 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001178/0000899243-19-001178-index.htm |
| 2019-01-15 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001180/0000899243-19-001180-index.htm |
| 2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001200/0000899243-19-001200-index.htm |
| 2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001201/0000899243-19-001201-index.htm |
| 2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001203/0000899243-19-001203-index.htm |
| 2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001204/0000899243-19-001204-index.htm |
| 2019-01-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001717/0000899243-19-001717-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319002185/0000899243-19-002185-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319002188/0000899243-19-002188-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319002189/0000899243-19-002189-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319002191/0000899243-19-002191-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319002192/0000899243-19-002192-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319002193/0000899243-19-002193-index.htm |
| 2019-01-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319002197/0000899243-19-002197-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319008784/0000899243-19-008784-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319019764/0000899243-19-019764-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319021944/0000899243-19-021944-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319022200/0000899243-19-022200-index.htm |
| 2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319023816/0000899243-19-023816-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319023989/0000899243-19-023989-index.htm |
| 2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319024242/0000899243-19-024242-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/0000899243-19-025608-index.htm |
| 2019-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025758/0000899243-19-025758-index.htm |
| 2019-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025822/0000899243-19-025822-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000090221919000105/0000902219-19-000105-index.htm |
| 2019-11-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000090221919000463/0000902219-19-000463-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000095012320000261/0000950123-20-000261-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000106299320000500/0001062993-20-000500-index.htm |
| 2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000110465920046138/0001104659-20-046138-index.htm |
| 2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000110465920048214/0001104659-20-048214-index.htm |
| 2020-05-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1512762/000110465920059847/0001104659-20-059847-index.htm |
| 2019-12-02 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1512762/000114036119021718/0001140361-19-021718-index.htm |
| 2018-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000114420418047629/0001144204-18-047629-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000114420419028264/0001144204-19-028264-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000114420419032103/0001144204-19-032103-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000114420419033657/0001144204-19-033657-index.htm |
| 2018-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312518202379/0001193125-18-202379-index.htm |
| 2018-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312518219674/0001193125-18-219674-index.htm |
| 2018-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312518233150/0001193125-18-233150-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312518242736/0001193125-18-242736-index.htm |
| 2018-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312518283952/0001193125-18-283952-index.htm |
| 2018-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312518317130/0001193125-18-317130-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312518322543/0001193125-18-322543-index.htm |
| 2018-11-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1512762/000119312518322615/0001193125-18-322615-index.htm |
| 2019-01-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519007367/0001193125-19-007367-index.htm |
| 2019-02-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1512762/000119312519025855/0001193125-19-025855-index.htm |
| 2019-02-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1512762/000119312519025857/0001193125-19-025857-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000119312519035894/0001193125-19-035894-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000119312519037999/0001193125-19-037999-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000119312519040451/0001193125-19-040451-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519057442/0001193125-19-057442-index.htm |
| 2019-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519079560/0001193125-19-079560-index.htm |
| 2019-04-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519099216/0001193125-19-099216-index.htm |
| 2019-04-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1512762/000119312519102805/0001193125-19-102805-index.htm |
| 2019-04-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1512762/000119312519102812/0001193125-19-102812-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519136915/0001193125-19-136915-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519142971/0001193125-19-142971-index.htm |
| 2019-05-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1512762/000119312519143027/0001193125-19-143027-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519158318/0001193125-19-158318-index.htm |
| 2019-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312519190538/0001193125-19-190538-index.htm |
| 2019-10-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1512762/000119312519267059/0001193125-19-267059-index.htm |
| 2019-11-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1512762/000119312519285782/0001193125-19-285782-index.htm |
| 2019-11-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1512762/000119312519288389/0001193125-19-288389-index.htm |
| 2020-01-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1512762/000119312520014265/0001193125-20-014265-index.htm |
| 2020-01-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1512762/000119312520014273/0001193125-20-014273-index.htm |
| 2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000119312520024207/0001193125-20-024207-index.htm |
| 2020-10-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000119312520265594/0001193125-20-265594-index.htm |
| 2020-01-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000120919120002581/0001209191-20-002581-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000155837020005682/0001558370-20-005682-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000155837020005749/0001558370-20-005749-index.htm |
| 2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000155837020006962/0001558370-20-006962-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000155837020009645/0001558370-20-009645-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000155837020009657/0001558370-20-009657-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000155837020009669/0001558370-20-009669-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000155837020012841/0001558370-20-012841-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000155837020012864/0001558370-20-012864-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000156459018020492/0001564590-18-020492-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000156459018028562/0001564590-18-028562-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1512762/000156459019005470/0001564590-19-005470-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000156459019018007/0001564590-19-018007-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000156459019027982/0001564590-19-027982-index.htm |
| 2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000156459019028841/0001564590-19-028841-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000156459019041086/0001564590-19-041086-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1512762/000156459019042255/0001564590-19-042255-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1512762/000156459020007383/0001564590-20-007383-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1512762/000156459020007416/0001564590-20-007416-index.htm |
| 2020-04-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1512762/000156459020015549/0001564590-20-015549-index.htm |
| 2020-04-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1512762/000156459020015776/0001564590-20-015776-index.htm |
| 2019-01-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1512762/000156761919000859/0001567619-19-000859-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919012553/0001567619-19-012553-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919012731/0001567619-19-012731-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/0001567619-19-021759-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919021956/0001567619-19-021956-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919022077/0001567619-19-022077-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919022127/0001567619-19-022127-index.htm |
| 2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919022189/0001567619-19-022189-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/0001567619-19-023319-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/0001567619-20-001038-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001039/0001567619-20-001039-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001040/0001567619-20-001040-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001041/0001567619-20-001041-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001042/0001567619-20-001042-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001043/0001567619-20-001043-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001044/0001567619-20-001044-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001045/0001567619-20-001045-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001046/0001567619-20-001046-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001047/0001567619-20-001047-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001048/0001567619-20-001048-index.htm |
| 2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm |
| 2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004636/0001567619-20-004636-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920005741/0001567619-20-005741-index.htm |
| 2020-04-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/0001567619-20-010834-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920011016/0001567619-20-011016-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012456/0001567619-20-012456-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/0001567619-20-012458-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012977/0001567619-20-012977-index.htm |
| 2020-07-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm |
| 2020-08-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920014072/0001567619-20-014072-index.htm |
| 2020-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920014073/0001567619-20-014073-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920016242/0001567619-20-016242-index.htm |
| 2020-09-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920017365/0001567619-20-017365-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920017922/0001567619-20-017922-index.htm |
| 2020-10-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm |
| 2018-08-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1512762/999999999718007359/9999999997-18-007359-index.htm |
| 2020-05-12 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1512762/999999999720002749/9999999997-20-002749-index.htm |
Coherus BioSciences, Inc (CHRS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Coherus BioSciences, Inc (CHRS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 162%Institutional Ownership: 12564%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-22 | Mary T Szela | Director | Sell | 54,997.00 | 17.58 | 966,759.26 | 0.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm |
| 2020-06-17 | Mats Wahlstrom | Director | Sell | 200,000.00 | 17.15 | 3,430,020.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012456/0001567619-20-012456-index.htm |
| 2019-10-16 | Jean-Frederic Viret | Chief Financial Officer | Buy | 3,159.00 | 10.05 | 31,747.95 | 10,932.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025758/0000899243-19-025758-index.htm |
| 2019-06-19 | Jean-Frederic Viret | Chief Financial Officer | Sell | 667.00 | 20.00 | 13,340.00 | 11,513.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm |
| 2019-06-19 | Jean-Frederic Viret | Chief Financial Officer | Sell | 100.00 | 20.81 | 2,081.00 | 11,513.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm |
| 2019-06-19 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,059.00 | 20.32 | 62,166.22 | 11,613.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm |
| 2019-09-18 | Jean-Frederic Viret | Chief Financial Officer | Buy | 3,159.00 | 10.05 | 31,747.95 | 11,672.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319023989/0000899243-19-023989-index.htm |
| 2019-06-18 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,000.00 | 19.31 | 57,926.40 | 12,180.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm |
| 2019-05-30 | Dennis M Lanfear | President & CEO | Sell | 32,398.00 | 19.49 | 631,281.51 | 1,284,184.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919012553/0001567619-19-012553-index.htm |
| 2019-03-20 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,000.00 | 14.92 | 44,762.10 | 13,185.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319008784/0000899243-19-008784-index.htm |
| 2019-01-11 | Dennis M Lanfear | President and CEO | Buy | 50,265.00 | 142,884.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001204/0000899243-19-001204-index.htm | ||
| 2019-08-21 | Jean-Frederic Viret | Chief Financial Officer | Sell | 260.00 | 20.73 | 5,388.68 | 14,571.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm |
| 2019-06-19 | Jean-Frederic Viret | Chief Financial Officer | Buy | 3,159.00 | 10.05 | 31,747.95 | 14,672.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319017621/0000899243-19-017621-index.htm |
| 2019-08-21 | Jean-Frederic Viret | Chief Financial Officer | Buy | 6,318.00 | 10.05 | 63,495.90 | 14,831.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm |
| 2020-06-22 | Mary T Szela | Director | Buy | 14,997.00 | 2.50 | 37,500.00 | 14,997.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm |
| 2020-01-10 | Dennis M Lanfear | President & CEO | Buy | 59,763.00 | 184,780.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001041/0001567619-20-001041-index.htm | ||
| 2019-07-15 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 19.20 | 48,000.00 | 19,310.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319019764/0000899243-19-019764-index.htm |
| 2019-08-14 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 19.00 | 47,500.00 | 19,310.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319021944/0000899243-19-021944-index.htm |
| 2019-09-16 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 20.03 | 50,075.00 | 19,310.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319023816/0000899243-19-023816-index.htm |
| 2019-10-14 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 18.40 | 46,000.00 | 19,310.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/0000899243-19-025608-index.htm |
| 2019-11-14 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 19.26 | 48,150.00 | 19,310.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/0001567619-19-021759-index.htm |
| 2020-07-01 | Dennis M Lanfear | President & CEO | Buy | 29,994.00 | 0.01 | 248.95 | 193,258.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012977/0001567619-20-012977-index.htm |
| 2019-12-16 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 18.69 | 46,725.00 | 19,326.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/0001567619-19-023319-index.htm |
| 2019-07-02 | JAMES HEALY | Director | Sell | 160,000.00 | 22.61 | 3,617,600.00 | 1,933,221.00 | https://www.sec.gov/Archives/edgar/data/1512762/000114420419033657/0001144204-19-033657-index.htm |
| 2020-03-03 | Mats Wahlstrom | Director | Sell | 4,222.00 | 20.89 | 88,214.89 | 200,000.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920005741/0001567619-20-005741-index.htm |
| 2020-03-03 | Mats Wahlstrom | Director | Sell | 113,844.00 | 20.09 | 2,287,194.27 | 204,222.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920005741/0001567619-20-005741-index.htm |
| 2019-06-28 | JAMES HEALY | Director | Sell | 200,000.00 | 22.05 | 4,410,000.00 | 2,093,221.00 | https://www.sec.gov/Archives/edgar/data/1512762/000114420419033657/0001144204-19-033657-index.htm |
| 2019-07-15 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 21,810.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319019764/0000899243-19-019764-index.htm |
| 2019-08-14 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 21,810.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319021944/0000899243-19-021944-index.htm |
| 2019-09-16 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 21,810.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319023816/0000899243-19-023816-index.htm |
| 2019-10-14 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 21,810.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025608/0000899243-19-025608-index.htm |
| 2019-11-14 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 21,810.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919021759/0001567619-19-021759-index.htm |
| 2019-12-16 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 21,826.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919023319/0001567619-19-023319-index.htm |
| 2019-01-11 | Jean-Frederic Viret | Chief Financial Officer | Buy | 16,685.00 | 22,482.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001203/0000899243-19-001203-index.htm | ||
| 2020-01-10 | Jean-Frederic Viret | Chief Financial Officer | Buy | 19,365.00 | 22,668.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001039/0001567619-20-001039-index.htm | ||
| 2019-06-20 | JAMES HEALY | Director | Sell | 317,130.00 | 21.37 | 6,777,068.10 | 2,293,221.00 | https://www.sec.gov/Archives/edgar/data/1512762/000114420419032103/0001144204-19-032103-index.htm |
| 2019-01-11 | Vladimir Vexler | Chief Scientific Officer | Buy | 15,562.00 | 23,390.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001200/0000899243-19-001200-index.htm | ||
| 2019-01-11 | Anicetti Vincent R | Chief Operating Officer | Buy | 16,997.00 | 23,699.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319001201/0000899243-19-001201-index.htm | ||
| 2019-05-22 | JAMES HEALY | Director | Sell | 257,870.00 | 20.69 | 5,335,330.30 | 2,610,351.00 | https://www.sec.gov/Archives/edgar/data/1512762/000114420419028264/0001144204-19-028264-index.htm |
| 2020-01-10 | Vladimir Vexler | Chief Scientific Officer | Buy | 8,900.00 | 28,412.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001040/0001567619-20-001040-index.htm | ||
| 2018-08-29 | JAMES HEALY | Director | Sell | 25,000.00 | 20.50 | 512,500.00 | 2,868,221.00 | https://www.sec.gov/Archives/edgar/data/1512762/000114420418047629/0001144204-18-047629-index.htm |
| 2020-01-09 | JAMES HEALY | Director | Buy | 29,994.00 | 1.67 | 50,000.00 | 30,086.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm |
| 2019-11-18 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,112.00 | 18.88 | 58,757.36 | 3,303.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919021956/0001567619-19-021956-index.htm |
| 2019-11-20 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,159.00 | 19.59 | 61,871.86 | 3,303.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919022077/0001567619-19-022077-index.htm |
| 2020-06-22 | Mary T Szela | Director | Buy | 20,000.00 | 10.05 | 201,000.00 | 34,997.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm |
| 2018-07-09 | FINCK BARBARA K | Chief Medical Officer | Sell | 500.00 | 15.03 | 7,515.00 | 37,043.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm |
| 2018-07-10 | FINCK BARBARA K | Chief Medical Officer | Sell | 1,260.00 | 15.00 | 18,900.00 | 37,043.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm |
| 2018-08-13 | FINCK BARBARA K | Chief Medical Officer | Sell | 1,760.00 | 19.02 | 33,479.95 | 37,043.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318022461/0000899243-18-022461-index.htm |
| 2018-09-10 | FINCK BARBARA K | Chief Medical Officer | Sell | 1,760.00 | 18.58 | 32,698.86 | 37,043.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318024270/0000899243-18-024270-index.htm |
| 2018-07-09 | FINCK BARBARA K | Chief Medical Officer | Buy | 500.00 | 1.42 | 710.00 | 37,543.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm |
| 2018-07-23 | Jean-Frederic Viret | Chief Financial Officer | Sell | 9,291.00 | 18.56 | 172,471.62 | 3,779.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318020572/0000899243-18-020572-index.htm |
| 2018-07-10 | FINCK BARBARA K | Chief Medical Officer | Buy | 1,260.00 | 1.42 | 1,789.20 | 38,303.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318019736/0000899243-18-019736-index.htm |
| 2018-08-13 | FINCK BARBARA K | Chief Medical Officer | Buy | 1,760.00 | 1.42 | 2,499.20 | 38,803.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318022461/0000899243-18-022461-index.htm |
| 2018-09-10 | FINCK BARBARA K | Chief Medical Officer | Buy | 1,760.00 | 1.42 | 2,499.20 | 38,803.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318024270/0000899243-18-024270-index.htm |
| 2020-01-10 | Anicetti Vincent R | Chief Operating Officer | Buy | 19,566.00 | 38,892.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/0001567619-20-001038-index.htm | ||
| 2020-10-14 | Jean-Frederic Viret | Chief Financial Officer | Sell | 6,144.00 | 19.00 | 116,736.00 | 40,423.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920017922/0001567619-20-017922-index.htm |
| 2019-11-21 | Dennis M Lanfear | President & CEO | Sell | 12,500.00 | 18.56 | 231,960.00 | 446,684.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919022189/0001567619-19-022189-index.htm |
| 2018-09-21 | Jean-Frederic Viret | Chief Financial Officer | Buy | 740.00 | 13.50 | 9,990.00 | 4,519.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924318025185/0000899243-18-025185-index.htm |
| 2019-11-20 | Dennis M Lanfear | President & CEO | Sell | 825,000.00 | 18.00 | 14,850,000.00 | 459,184.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919022127/0001567619-19-022127-index.htm |
| 2020-05-20 | Jean-Frederic Viret | Chief Financial Officer | Sell | 1,278.00 | 17.66 | 22,569.48 | 46,567.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920011016/0001567619-20-011016-index.htm |
| 2020-01-10 | Jean-Frederic Viret | Chief Financial Officer | Buy | 31,250.00 | 46,841.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001039/0001567619-20-001039-index.htm | ||
| 2020-01-15 | Jean-Frederic Viret | Chief Financial Officer | Sell | 2,798.00 | 20.08 | 56,185.80 | 46,841.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm |
| 2020-02-19 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,159.00 | 22.33 | 70,551.84 | 46,841.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004636/0001567619-20-004636-index.htm |
| 2020-04-20 | Anicetti Vincent R | Chief Operating Officer | Sell | 5,150.00 | 17.00 | 87,550.00 | 47,846.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm |
| 2020-05-18 | Anicetti Vincent R | Chief Operating Officer | Sell | 593.00 | 17.17 | 10,181.81 | 48,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/0001567619-20-010834-index.htm |
| 2020-06-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 17.22 | 43,050.00 | 48,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/0001567619-20-012458-index.htm |
| 2020-07-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 15,000.00 | 18.25 | 273,687.00 | 48,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm |
| 2020-08-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 5,000.00 | 19.37 | 96,851.00 | 48,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm |
| 2020-09-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 5,000.00 | 18.84 | 94,216.00 | 48,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm |
| 2020-10-19 | Anicetti Vincent R | Chief Operating Officer | Sell | 3,217.00 | 17.89 | 57,555.67 | 48,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm |
| 2020-01-15 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,520.00 | 19.67 | 69,238.05 | 49,639.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm |
| 2020-02-19 | Jean-Frederic Viret | Chief Financial Officer | Buy | 3,159.00 | 10.05 | 31,747.95 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004636/0001567619-20-004636-index.htm |
| 2020-01-09 | JAMES HEALY | Director | Buy | 20,000.00 | 10.05 | 201,000.00 | 50,086.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm |
| 2020-05-18 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 51,056.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920010834/0001567619-20-010834-index.htm |
| 2020-06-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 51,056.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012458/0001567619-20-012458-index.htm |
| 2020-07-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 51,056.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm |
| 2020-08-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 51,056.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm |
| 2020-09-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 51,056.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm |
| 2020-10-19 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 51,056.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm |
| 2020-10-19 | Anicetti Vincent R | Chief Operating Officer | Buy | 717.00 | 12.70 | 9,105.90 | 51,773.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920018056/0001567619-20-018056-index.htm |
| 2020-02-18 | Anicetti Vincent R | Chief Operating Officer | Sell | 5,000.00 | 21.64 | 108,190.00 | 52,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm |
| 2020-04-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 5,000.00 | 15.57 | 77,850.00 | 52,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm |
| 2020-01-15 | Jean-Frederic Viret | Chief Financial Officer | Buy | 6,318.00 | 10.05 | 63,495.90 | 53,159.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001235/0001567619-20-001235-index.htm |
| 2020-08-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 12.70 | 31,750.00 | 53,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920015756/0001567619-20-015756-index.htm |
| 2020-09-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 12.70 | 31,750.00 | 53,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920016945/0001567619-20-016945-index.htm |
| 2020-06-22 | Mary T Szela | Director | Buy | 20,000.00 | 12.37 | 247,400.00 | 54,997.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920012534/0001567619-20-012534-index.htm |
| 2020-01-10 | Vladimir Vexler | Chief Scientific Officer | Buy | 31,250.00 | 56,185.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001040/0001567619-20-001040-index.htm | ||
| 2020-04-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 5,000.00 | 2.50 | 12,502.50 | 57,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920008227/0001567619-20-008227-index.htm |
| 2020-01-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 5,000.00 | 19.56 | 97,796.00 | 57,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm |
| 2020-01-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 19.69 | 49,213.25 | 57,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm |
| 2020-02-18 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 21.64 | 54,100.00 | 57,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm |
| 2020-01-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 12.70 | 31,750.00 | 60,496.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm |
| 2020-02-18 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 12.70 | 31,750.00 | 60,496.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm |
| 2020-02-18 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 60,496.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920004436/0001567619-20-004436-index.htm |
| 2020-01-10 | Anicetti Vincent R | Chief Operating Officer | Buy | 31,250.00 | 62,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001038/0001567619-20-001038-index.htm | ||
| 2020-01-17 | Anicetti Vincent R | Chief Operating Officer | Sell | 2,500.00 | 19.57 | 48,921.25 | 62,996.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm |
| 2020-07-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 12,500.00 | 12.70 | 158,750.00 | 63,556.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920013539/0001567619-20-013539-index.htm |
| 2019-10-18 | Jean-Frederic Viret | Chief Financial Officer | Sell | 1,388.00 | 19.02 | 26,399.76 | 6,385.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025822/0000899243-19-025822-index.htm |
| 2019-11-20 | Jean-Frederic Viret | Chief Financial Officer | Buy | 3,159.00 | 10.05 | 31,747.95 | 6,462.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761919022077/0001567619-19-022077-index.htm |
| 2020-01-17 | Anicetti Vincent R | Chief Operating Officer | Buy | 2,500.00 | 2.50 | 6,251.25 | 65,496.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920001353/0001567619-20-001353-index.htm |
| 2020-01-12 | JAMES HEALY | Director | Buy | 20,000.00 | 12.37 | 247,400.00 | 70,086.00 | https://www.sec.gov/Archives/edgar/data/1512762/000156761920000939/0001567619-20-000939-index.htm |
| 2019-09-23 | Jean-Frederic Viret | Chief Financial Officer | Sell | 740.00 | 21.78 | 16,117.20 | 7,773.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319024242/0000899243-19-024242-index.htm |
| 2019-10-16 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,159.00 | 19.00 | 60,021.00 | 7,773.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319025758/0000899243-19-025758-index.htm |
| 2019-08-19 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,000.00 | 19.04 | 57,120.00 | 8,513.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319022200/0000899243-19-022200-index.htm |
| 2019-08-21 | Jean-Frederic Viret | Chief Financial Officer | Sell | 6,058.00 | 21.75 | 131,765.74 | 8,513.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319022360/0000899243-19-022360-index.htm |
| 2019-09-18 | Jean-Frederic Viret | Chief Financial Officer | Sell | 3,159.00 | 20.44 | 64,559.85 | 8,513.00 | https://www.sec.gov/Archives/edgar/data/1512762/000089924319023989/0000899243-19-023989-index.htm |